Loading...
Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides
BACKGROUND: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation to combat the rapid increase in MDR bacterial pathogens. However, many AMPs closely resemble components of the human innate immune system and the ramifications of prolonged bacterial exposure to AMPs...
Na minha lista:
| Udgivet i: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161045/ https://ncbi.nlm.nih.gov/pubmed/27650186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw381 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|